Co-culture of apatinib-treated HUVEC cells with pyrotinib-treated HER2-positive GC cells revealed no significant difference in cell survival, proliferation, or malignant properties in the GC cells relative to controls. The gene discussed is ERBB2; the disease is gastric cancer.